RxDoctor Payments DataLook up a doctor →

Marcus Norris, NP

Adult Health · Germantown, TNNPI 1962591362

Payments from drug & device makers

$7,272in general payments, 2019–2025

Across 349 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$633
  • Gilead$574
  • Merck$500
  • Johnson & Johnson$493
  • Novartis$451
  • Pfizer$391
  • plus $4K from 44 others

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)33$633
Gilead17$574
Merck23$500
Johnson & Johnson(2 entities)28$493
Novartis25$451
Pfizer23$391
GSK23$369
Eisai Inc.16$325
Takeda Pharmaceuticals U.S.A., Inc.14$301
Lilly USA, LLC12$272
Bristol Myers Squibb9$236
Astellas Pharma US Inc6$196
E.r. Squibb & Sons, L.L.C.11$193
AbbVie8$190
Taiho Oncology, Inc.9$147
Seagen Inc.5$147
Incyte Corporation3$138
Pharmacyclics LLC, An Abbvie Company8$134
Beigene USA, Inc.6$132
Genentech USA, Inc.5$104
Sumitomo Pharma America, Inc.3$88
Tersera Therapeutics LLC4$80
Legend Biotech USA Inc.3$78
Morphosys, US Inc.1$74
Jazz Pharmaceuticals Inc.4$72
Exelixis Inc.4$71
Tempus AI, Inc4$70
Sobi, Inc3$62
Array Biopharma Inc3$58
AVEO Pharmaceuticals, Inc.3$53
Beone Medicines USA, Inc.2$51
Rigel Pharmaceuticals, Inc.3$50
Geron Corporation3$50
Genmab U.S., Inc.2$48
Daiichi Sankyo Inc.2$41
Amgen2$41
Syndax Pharmaceuticals, Inc.2$41
Stemline Therapeutics Inc.2$37
Bayer2$36
Boehringer Ingelheim2$34
Kyowa Kirin, Inc.2$28
Adaptive Biotechnologies Corporation1$27
EMD Serono, Inc.1$25
Recordati_rare_diseases_inc.1$23
Regeneron Healthcare Solutions, Inc.1$22
Azurity Pharmaceuticals, Inc.1$22
Pharmaessentia USA Corporation1$19
Sanofi1$16
Pharmacosmos Therapeutics Inc.1$16
Caris MPI, Inc.1$14

How this compares

$7,272 in reported general payments places this provider in the 90th percentile of 352 adult health providers in Tennessee.

See all adult health providers in Tennessee →

Medicare billing

Part B allowed, 2024
$759,089
Medicare patients
533
Services billed
30,178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Germantown

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →